Do not take ALA (alpha-lipoic acid) for migraines- at least for now.
Posted on June 22 2022,
Alpha-Lipoic Acid or ALA is most commonly known for its use in patients with diabetic neuropathy.
In the most recent study evaluating ALA for migraines, it was found that "no significant changes were observed for NO levels and duration of migraine pains."
Moreover, ALA was found to reduce the lifespan of mice.
https://pubmed.ncbi.nlm.nih.gov/22785389/
Healthy mice treated long-term with ALA developed hepatic steatosis and liver injury. The effect of long-term ALA supplementation in humans is currently unknown and, therefore, it is possible that similar negative effects could be observed.
With the risk of shortening lifespan and causing injury, ALA is just not worth the risk especially with limited to no benefit.
Mon, May 19, 25
Migraine and Headaches During Pregnancy & Postpartum
Comprehensive guidance on managing migraine and headaches during pregnancy and postpartum. Learn about effective treatments, safety considerations, and when to seek medical help. Discover evidence-based strategies for relief, including medication...
Read MoreMon, May 19, 25
Pharmaceutical Options for Migraine Prevention
A comprehensive guide to medication classes, efficacy, dosing, and considerations for personalized preventive treatment
Read MoreThu, May 15, 25
Modifiable Risk Factors for Migraine: What You Can Change
Table of modifiable migraine risk factors based on recent research
Read More